期刊文献+

洛沙平与利培酮治疗精神分裂症的对照研究 被引量:2

A comparative study of loxapine and risperidone in the treatment of schizophrenic patients
下载PDF
导出
摘要 目的 研究洛沙平与利培酮治疗精神分裂症的临床疗效及安全性。方法 63 例精神分裂症患者随机分成2组,分别给予洛沙平与利培酮治疗8 周,并用 PANSS量表评价临床疗效,TESS评价不良反应。结果 两组之间疗效无显著差异,洛沙平起效快。洛沙平常见副反应有锥体外系反应(EPS)。结论 洛沙平是一种安全、有效和起效快的抗精神病药物。 Objective To study the efficacy of loxapine and risperidone in the treatment of schizophrenia.Methods A total of 63 patients were randomly assigned to receiving loxapine or risperidone for 8 weeks.PANSS and TESS were used to measure the efficacy.Results There were no significant differences in the total curative effects between two groups(P>0.05).The main side effect of loxapine was extrapyramidal side effect.Conclusion Loxapine is an effective and safe antipsychotic agent.
出处 《山东精神医学》 2005年第1期28-29,共2页 Shangdong Archives of Psychiatry
关键词 精神分裂症 洛沙平 利培酮 对照研究 Schizophernia Loxapine Risperidone
  • 相关文献

参考文献5

二级参考文献13

  • 1谢斌,郑瞻培.抗精神病药物洛沙平的研究现状[J].新药与临床,1993,12(6):359-361. 被引量:8
  • 2张明远.精神科评定量表手姆 第2版[M].长沙:湖南科学技术出版社,1998.81—211.
  • 3[1]Kapur S, Zipursky RB, Jones C, et al. The D2 receptor occupancy profile of loxapine determined using PET. Neuropsychopharmacology.1996 Dec; 15(6): 562~566
  • 4[2]Roth BL, Craigo SC, Choudhary MS, et al. Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors. J Pharmacol Exp Ther 1994 Mar;268(3) :1403~1410
  • 5[3]Singh AN, Barlas C, Singh S, et al. A neurochemieal basis for the antipsychotie activity of loxapine: interactions with dopamine D1, D2 ,D4 and serotonin 5-HT2 receptor subtypes. J Psychiatry-Neurosci.1996 Jan; 21(1): 29~35
  • 6[4]Kapur S, Zipursky R, Remington G, et al. PET evidence that loxapine is an equipotent blocker of 5-HT2 and D2 receptors: implications for the therapeutics of schizophrenia. Am J Psychiatry. 1997 Nov;154(11): 1525~1529
  • 7[5]William M, Glazer MD. Dose loxapine have "Atypical" properties?clinical evidence. J C lin Psychiatry. 1999 ;60 (supple 10): 42~46
  • 8[6]Peter F, Buckley, MD. The role of typical and atypical antipsychotics medication in the management of agitation and aggression. J Clin Psychiatry. 1999 ;60(supple 10): 52~60
  • 9[7]Meltzer HY, Jayathilake K. Low-dose loxapine in the treatment of schizophrenia: is it more effective and more "atypical" than standard - dose loxapine? J Clin Psychiatry. 1999; 60 Suppl 10: 47~51
  • 10[9]Ereshefsky L. Pharmacologic and pharmacokinetic considerations in choosing an antipsychotic. J Clin Psychiatry. 1999; 60 Suppl 10: 20~30

共引文献43

同被引文献21

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部